Radiation therapy for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests if a targeted radiation therapy can help people with early-stage Parkinson's disease that affects only one side of the body. It aims to see if this treatment can slow down the disease and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 70 years old.
- A movement disorder specialist has diagnosed you with Parkinson's disease.
- A special brain scan (DaT scan) shows your Parkinson's is only on one side of your body.
- Your Parkinson's symptoms are mild, scoring 2 or less on a standard scale.
- You are generally able to care for yourself and perform daily activities without needing constant help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This trial tests whether precisely targeted radiation to the brain can reduce tremors in people whose symptoms are not controlled enough by medication. It may help those who prefer radiation over deep brain surgery options.
This trial tests a precise type of radiation therapy (PRaG) for people aged 75 and older whose cancer has spread or cannot be treated with standard options. The goal is to see if this treatment can help control the tumor and improve quality of life.
This trial tests a new treatment made from your own cells to replace damaged brain cells, aiming to improve movement and reduce symptoms. It's for people who have had Parkinson's for at least 4 years and respond well to levodopa.
This trial is studying the “superior cervical ganglion” as a possible treatment approach for Parkinson’s disease. It may help people whose symptoms are truly caused by Parkinson’s, not by another condition.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.